We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
It’s possible to detect the potentially stroke-inducing cardiac condition atrial fibrillation effectively and more cheaply using wearable devices, according to researchers at Harvard Medical School and Massachusetts General Hospital. Read More
Omaha, Neb.-based medical imaging software company Bot Image has received FDA clearance for its ProstatID tool, a cloud-based artificial intelligence (AI) software product that helps detect and diagnose prostate cancer. Read More
Recalls can be messy, complicated matters, especially for manufacturers that don’t have a plan in place for analyzing a problem, determining a course of action and carrying out all recall-related tasks in compliance with FDA requirements. Read More
Only 45 percent of cancer drug trials made their individual participant data (IPD) available to other qualified researchers over the past 10 years, according to a new study. Read More
Pfizer announced that it will pay $5.4 billion for Global Blood Therapeutics (GBT), manufacturer of Oxbryta (voxelotor), one of a handful of drugs for treating sickle cell anemia. Read More
FDA has approved Enhertu (fam-trastuzumab-deruxtecan-nxki), the first approved therapy targeted to patients with unresectable or metastatic HER2-low breast cancer subtype, a newly defined subset of HER2-negative breast cancer. Read More